Evaluation of Serum Biomarkers to Inform Anemia Management in Individuals with Chronic Liver Disease - Takeaways - MDSpire

Evaluation of Serum Biomarkers to Inform Anemia Management in Individuals with Chronic Liver Disease

  • By

  • Yihui Rong

  • Wenpeng Fu

  • Yanyu Jiang

  • Xudong Gao

  • Jie Han

  • April 29, 2026

  • 0 min

Share

  • 1

    Chronic liver disease (CLD) affects 1.5 billion people globally, with 75% of patients experiencing anemia as a significant complication.

  • 2

    The study analyzed 119 patients with CLD to investigate the correlations between anemia-related biomarkers and disease severity.

  • 3

    Erythropoietin levels were positively correlated with soluble transferrin receptor in patients with macrocytic and normocytic anemia.

  • 4

    Various biomarkers showed statistical significance across different anemia types, indicating their potential role in evaluating liver function.

  • 5

    The findings suggest that anemia-related biomarkers may aid in managing anemia in CLD, warranting further validation in larger cohorts.

Original Source(s)

Evaluation of Serum Biomarkers to Inform Anemia Management in Individuals with Chronic Liver Disease

  • by Yihui Rong, Wenpeng Fu, Yanyu Jiang, Xudong Gao, Jie Han

  • April 29, 2026

Related Content

The impact of anemia and blood transfusion on mortality after open abdominal surgery in the elderly

Predictive model for in-hospital acute cerebral infarction in patients with acute gastrointestinal bleeding: a retrospective cohort study

Clinical Findings in Migrants With Asymptomatic Plasmodium Infections